MANAGEMENT OF DYSLIPIDEMIA IN PRIMARY CARE

Bibliography

4S. See Scandinavian Simvastatin Survival Study Group.

Abstracts of Clinical Care Guidelines. (1997). The Joint Commission on Accreditation of Healthcare Organizations, 8(5), 1-8, 14-15.

ACC/AHA/ACP-ASIM Guidelines. See Gibbons.

AFCAPS/TexCAPS. See Downs.

American College of Physicians (ACP). (1996). Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. Part 1.   Annals of Internal Medicine, 124(5), 515-517.

American College of Sports Medicine (ACSM) Guidelines for Exercise Testing and Prescription, Fifth Edition (1995). Baltimore: Williams & Wilkins, pp. 162, 174.

American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness and flexibility in health adults. (1998).   Medical Science and Sports Exercise. 30(6), 975-991.

American Diabetes Association (ADA). Position statement: Management of dyslipidemia in adults with diabetes. (1998).   Diabetes Care. 21(1), 179-182.

Anderssen, S. A., Haaland, A., Hjermen, I., Urdal, P., Gjesdal, K., & Holme, I. (1995). Oslo diet and exercise study: a one year randomized intervention trial. Effect on haemostatic variables and other coronary risk factors.   Nutrition Metabolism in Cardiovascular Disease. 5, 189-200.

Atkings, D. A. & DiGuiseppi, C. Screening for high blood cholesterol and other lipid abnormalities. In: DiGuiseppi, C., Atkins, D., Woolf, S. H., Kamerow, D. B. eds. U.S. Preventive Services Task Force. (1996).   Guide to Clinical Preventive Services. Second edition. Alexandria: International Medical Publishing, 15-38.

Barrett-Connor, E., Khaw, K. (1984). Family history of heart attack as an independent predictor of death due to cardiovascular disease.   Circulation. 69, 1065-1069.

Beresford, S. A., Curry, S. J., Kristal, A. R., Lazovich, D., Feng, Z., & Wagner, E. H. (1997). A dietary intervention in primary care practice: the Eating Patterns Study.   American Journal of Public Health. 87(4), 610-616.

Bergstrand, R., Vedin, A., Wilhelmsson, C., Wallin, J., Wedel, H., Wilhelmsen, L. (1978). Myocardial infarction among men below age 40.   British Heart Journal. 40, 783-788.

Berlin, J. A., & Colditz, G. A. (1990). A meta-analysis of physical activity in the prevention of coronary heart disease.   American Journal of Epidemiology. 132, 612-628.

Blair, S. N. (1994). Physical activity, fitness, and coronary heart disease. In Bouchard, C., Shephard, R. J., Stephens, T. (eds). (1994).   Physical activity, Fitness and Health: International Proceedings and Consensus Statement. Champaign, IL: Human Kinetics, 579-380.

Blankenhorn, D. H., Nessim, S. A., Johnson, R. L., Sanmarco, M. E., Azen, S. P., & Cahsin-Hemphill, L. (1987). Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.   Journal of The American Medical Association. 257(23), 3233-3240.

Brannon, S. D., Tershakovec, A. M., Shannon, B. M. (1997). The cost-effectiveness of alternative methods of nutrition education for hypercholesterolemic children.   American Journal of Public Health,87(12), 1967-1970.

Brown, G., Albers, J., Fisher, L., Schaefer, S., Lin, J., Kaplan, C., Zhao, X., Bisson, B., Fitzpatrick, V., & Dodge, H. (1990). Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.   New England Journal of Medicine. 323(19), 1289-1298.

Brown, M. (1999). Do vitamin E and fish oil protect against ischaemic heart disease?   Lancet 354(9177), 441-442.

Caggiula, A. W., Watson, J. E., Kuller, L. H., Olson, M. B., Milas, N. C., Berry, M. & Germanowski, J. (1996). Cholesterol-lowering intervention program. Effect of the Step I diet in community office practices.   Archives of Internal Medicine,156(11), 1205-1213.

Califf, R., Armstrong, P., Carver, J., D'Agostino, R., & Strauss, W. (1996). 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.   Journal of the American College of Cardiology. 27, 1007-1012.

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986). Fifteen year mortality in coronary drug project patients: long term benefit with niacin.   Journal of the American College of Cardiology. 8(6), 1245-1255.

CARE. See Sacks.

Castelli, W. P. (1984). Epidemiology of coronary heart disease: the Framingham Study.   American Journal of Medicine. 76(2A), 4-12.

Castelli, W. P., Garrison, R. J., Wilson, P. W. F., Abbott, R. D., Kalousdian, S., & Kannel, W. B. (1986). Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study.   Journal of the American Medical Association. 256, 2835-2838.

Cater, N. B. Plant stanol ester foods: new tools in the dietary management of cholesterol. (1999).   Nutrition and the MD,25(11).

Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Examination statistics. Unpublished data.

CLAS. See Blankenhorn.

Cooper, G. R., Myers, G. L., Smith, S. J., & Schlant, R. C. (1992). Blood lipid measurements. Variations and practical utility.   Journal of the American Medical Association. 267(12), 1652-1660.

Coronary Drug Project. See Guyton.

Cress, M. E., Buchner, D. M., Questad, K. A., Esselman, P. C., deLateur, B. J., & Schwartz, R. S. (1999). Exercise: effects on physical functional performance in independent older adults.   Journal of Gerontology Series A, Biological Sciences and Medical Sciences. 54(5), M242-8.

Criqui, M. H. & Golomb, B. A. (1998). Epidemiologic aspects of lipid abnormalities.   American Journal of Medicine. 105(1A), 48S-57S.

Diabetes Control and Complications Trial Research Group (DCCT). (1993). The effect of intensive treatment of diabetes on the development and progression of long-tern complications in insulin-dependent diabetes mellitus.   New England Journal Medicine, 329, 977-986.

Diabetes Control and Complications Trial Research Group (DCCT). (1995). Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.   American Journal of Cardiology, 75(14), 894-903.

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. (1999).   Lancet, 354(9177), 447-455.

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Lagendorfer, A., Stein, E. A., Kruyer, W., & Gotto, A. M. Jr. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.   Journal of the American Medical Association, 279(20), 1615-1622.

Ebrahim, S. & Davey, & Smith, G. (1999). Multiple risk factor interventions for primary prevention of coronary heart disease.   The Cochrane Database of Systematic Reviews. Issue 4.

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. (1998).   Archives of Internal Medicine. 158(17), 1855-1867.

Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on the detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). (2001).   Journal of the American Medical Association. 285(19), 2486-2497.

FATS. See Brown, G.

Fiore, M. C., Smith, S. S., Jorenby, D. E., & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation: a meta-analysis.   Journal of the American Medical Association. 271, 1940-1947.

FLARE. See Serruys.

Fletcher, G. F. (1997). How to implement physical activity in primary and secondary prevention. a statement for healthcare professionals from the task force on risk reduction, American Heart Association.   Circulation 96. 355-357.

Fletcher, G. F., Balady, G., Blair, S. N., Blumenthal, J., Caspersen, C., Chaitman, B., Epstein, S., Sivarajan, Froelicher, E. S., Froelicher, V. F., Pina, I. L., & Pollock, M. L. (1996). Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association.   Circulation. 94(4), 857-862.

Frick, M., Elo, O., Happa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., & Manninen, V. (1987). Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.   New England Journal of Medicine.317(20), 1237-1245.

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.   Clinical Chemistry. 18(6), 499-502.

Frolich, J., Fodor, G., McPherson, R., Genest, J., & Langner, N. (1998). Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: Interim report.   Canadian Journal of Cardiology. 14(Suppl A), 17A-21A.

Frost, P. H. & Havel, R. J. (1998). Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.   American Journal of Cardiology. 81(4A), 26B-31B.

Garber, A. M., Browner, W. S., & Hulley, S. B. (1996). Cholesterol screening in asymptomatic adults, revisited.   Annals of Internal Medicine. 124, 518-531.

Gibbons, R., Chatterjee, K., Daley, J., Douglas, J., Fihn, S., Gardin, J., Grunwald, M., Levy, D., Lytle, B., O'Rourke, R., Schafer, W., Williams, S., Ritchie, J., Cheitlin, M., Eagle, K., Gardner, T., Garson, A., Russell, R., Ryan, T., & Smith, S.(1999). ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina).   Journal of the American College of Cardiology. 33(7), 2092-2197.

GISSI. See Dietary supplementation.

Glover, M. U., Kuber, M. T., Warren, S. E., & Vieweg, W. V. (1982). Myocardial infarction before age 36: risk factor and arteriographic analysis.   American Journal of Cardiology. 49, 1600-1603.

Glynn, T. J. & Manley, M. W. (1990). How to help your patients stop smoking: a National Cancer Institute manual for physicians. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. NIH Publication No. 90-3064.

Gordon, D. J., Probstfeld, J. L., & Garrison, R. J. (1989). High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies.   Circulation. 79, 8-15.

Gosselin, P., Verreault, R., Gaudreault, C., & Guillemette, J.(1996). Dietary treatment of mild to moderate hypercholesterolemia. Effectiveness of different interventions.   Canadian Family Physician, 42, 2160-2167.

Guyton, J. (1998). Effect of niacin on atherosclerotic cardiovascular disease.   American Journal of Cardiology. 82(12A), 18-23.

Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K. & Laasko, M. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction.   New England Journal of Medicine. 339, 229-234.

Hall, J. A., Roter, D. L. & Katz, N. R. (1988). Meta-analysis of correlates of provider behavior in medical encounters.   Medical Care. 26, 657-675.

Haskell, W. (1984). Exercise-induced changes in plasma lipids and lipoproteins.   Preventive Medicine 13, 23-36.

Haskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S. F., Superko, H. R., Williams, P. T., Johnstone, I. M., Champagne, M. A., & Drauss, R. M. (1994). Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease.   Circulation, 89(3), 975-990.

Hebert, J. R., Ebbeling, C. B., Ockene, I. S., Ma, Y., Rider, L., Merriam, P. A., Ockene, J. K., & Saperia, G. M. (1999). A dietitian-delivered group nutrition program leads to reduction in dietary fat, serum cholesterol, and body weight: The Worcester Area Trial for Counseling in Hyperlipidemia (WATCH).   Journal of the American Dietetic Association. 99(5), 544-552.

Helsinki Heart Study. See Frick.

Hjermann, I., Holme, I., & Leren, P. (1986). Oslo study diet and anti-smoking trial.   American Journal of Medicine. 80(suppl 2A), 7-11.

Hjermann, I., Holme, I., Velve Byre, K., & Leren, P. (1981). Effect of diet and smoking on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomized trial in healthy men.   Lancet. ii, 1303-1310.

Holme, I., Hjermann, I., Helgeland, A., & Leren, P. (1985). The Oslo Study; diet and anti-smoking advice. Additional results from a 5-year primary preventive trial in middle-aged men.   Preventive Medicine. 14, 279-292.

Hunt, S. C., Williams, R. R., & Barlow, G. K. (1986). A comparison of positive family history definitions for defining risk of future disease.   Journal of Chronic Disease. 39, 809-821.

Joint British recommendations on prevention of coronary heart disease in clinical practice. (1998). British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society. Endorsed by the British Diabetic Association.   Heart. 80(2S), 1S-29S.

Jones, P. H., Farmer, J. A., Cressman, M. D., McKenney, J. M., Wright, J. T., Proctor, J. D., Berkson, D. M., Farnham, D. J., Wolfson, P. M., & Colfer, H. T. (1991). Once-daily pravastatin in patients with primary hypercholesterolemia: a dose response study.   Clinical Cardiology. 14(2), 146-151.

Kannel, W. B. (1978). Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease.   Annals of the New York Academy of Science. 304, 128-139.

Kannel, W. B. & McGee, D. L. (1979). Diabetes and cardiovascular disease. The Framingham study.   Journal of the American Medical Association. 241, 2035-2038.

Kris-Etherton, P. & Burns, J. (eds). (1998).   Cardiovascular Nutrition: Strategies and Tools for Disease Management and Prevention. American Dietetic Association, Chicago, IL.

Leng, G. C., Price, J. F., & Jepson, R. G. (1999). Lipid-lowering pharmacotherapy for lower-limb atherosclerosis.   Cochrane Database of Systematic Reviews. Issue 4.

Lindholm, L. H., Ekbom, T., Dash, C., Eriksson, M., Tibblin, G. & Schersten, B. (1995). The impact of health care advice in primary care on cardiovascular risk. CELL study Group.   British Medical Journal. 310(6987), 1105-1109.

Lipid Research Clinics Program. (1984). The Lipid Research Clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease.   Journal of the American Medical Association. 241, 351-364.

Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.   New England Journal of Medicine. 339, 1349-1357.

Lovastatin Study Groups I through IV. (1993). Lovastatin 5-year safety and efficacy study.   Archives of Internal Medicine. 153, 1079-1087

MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A., & Stamler, J. (1990). Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure, stroke: prospective observational studies corrected for the regression dilution bias.   Lancet. 335(8692), 765-774.

Mazzeo, R. S., Cavanagh, P., Evans, W. J., Fiatarone, M., Hagberg, J., McAuley, E., & Startzell, J. (1998). American College of Sports Medicine Position Stand. Exercise and physical activity for the older adult.   Medical Science and Sports Exercise. 30(6), 992-1008.

McCarron, D. A., Oparil, S., Chait, A., Haynes, R. B., Kris-Etherton, P., Stern, J. S., Resnick, L M., Clark, S., Morris, C. D., Hatton, D. C., Metz, J. A., McMahon, M., Holcomb, S., Snyder, G. W., & Pi-Sunyer, F. X. Nutritional Management of cardiovascular risk factors. A randomized clinical trial.   Archives in Internal Medicine. 157(2), 169-177.

McGehee, M. M., Johnson, E. Q., Rasmussen, H. M., Sahyoun, N., Lynch, M. M. & Carey, M. (1995). Benefits and costs of medical nutrition therapy by registered dietitians for patients with hypercholesterolemia.   Journal of the American Dietetic Association. 95(9),1041-1043.

McGinnis, J. M. & Foege, W. H. (1993). Actual causes of death in the United States.   Journal of the American Medical Association. 270, 2207-2212.

Medical Nutrition Across the Continuum of Care. (1998). Second Edition. The American Dietetic Association, Chicago, IL.

Medical Research Council (MRC) Working Party. (1992). Medical Research Council trial of treatment of hypertension in older adults: principal results.   British Medical Journal. 304, 405-412.

Merritt, R. J. (1999). Soy Protein Health Claim Gets FDA Authorization.   Nutrition and the MD. 25(11).

Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilento J. (1998). Impact of diabetes on mortality after the first myocardial infarction.   Diabetes Care. 21(1):69-75

Multiple Risk Factor Intervention Trial (MRFIT) Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results.   Journal of the American Medical Association. 248,1465-1477.

Murray, C. J. L., Lopez, A. D. (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Diseases Study.   Lancet, 349(9063), 1436-1442.

National Cancer Institute (NCI). (1994). Tobacco and the clinician: interventions for medical and dental practice. NIH publication No 94-3693.   National Cancer Institute. 5, 1-22.

National Cholesterol Education Program (NCEP). (1993). Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). NIH Publication 93-3095, National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

NCEP II. Also see Summary.

NCEP III. See Executive Summary.

Neaton, J. D. & Wentworth, D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men.   Archives of Internal Medicine. 152, 56-64.

NIH Consensus Conference: Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. (1993).   Journal of the American Medical Association. 269(4), 55-100.

NIH Consensus Conference on triglyceride, high-density lipoprotein, and coronary heart disease. (1993).   Journal of the American Medical Association, 269(4), 505-510.

OASD(HA) Policy 97-055. Memorandum for Surgeons General: Policy for Medical Nutrition Therapy (MNT) in Direct Care Clinical Practice, 1997

Oberman, A., Kriesberg, R., & Henkin, Y. (1992).   Secondary dyslipidemia. In principles and management of lipid disorders. (pp. 154-70). Baltimore: Williams & Wilkins.

Ockene, J. K. (1987). Smoking intervention: The expanding role of the physician.   American Journal of Public Health. 77, 782-783.

Ockene, J. K., Kristellar, J., Goldberg, R., Amick, T. L., Pekow, P. S., Hosmer, D., Quirk, M. & Kalan, K. (1991). Increasing the efficacy of physician-delivered interventions: a randomized clinical trial.   Journal of General Internal Medicine. 6, 1-8.

Ornish, D., Brown, S. E., Scherwitz, L. W., Billings, J. H., Armstrong, W. T., Porta, T. A., McLanahan, S. M., Kirkeeidee, R. L., Brand, R. J., & Gould, K. L. (1990). Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.   Lancet. 336:129-133.

Oslo. See Anderssen.

Oslo. See Holme.

Oslo. See Hjermann.

Pate, R. R., Pratt, M., Blair, S. N., Haskell, W. L., Macera, C. A., Bouchard, C., Buchner, D., Ettinger, W., Heath, G. & King, A. C. (1995). Physical activity and public health. A recommendation from the Center for Disease Control and Prevention and the American College of Sports Medicine.   Journal of the American Medical Association. 273, 402-407.

Pederson, L. L. (1982). Compliance with physician advice to quit smoking: a review of the literature.   Preventive Medicine. 11, 71-84.

Pharmacy Benefits Management-Medical Advisory Panel. (1997).The pharmacologic management of hyperlipidemia. VHA PBM-SHG Publication. Hines, IL: Pharmacy Benefits Management Strategic Health Group, Veterans Health Administration, Department of Veterans Affairs.

Physical activity and health: A report of the Surgeon General, U.S. Department of Health and Human Services; Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. The President's Council on Physical Fitness and Sports, 1996

Piolot, A., Nadler, F., Cavallero, E., Coquard, J. L., & Jacotot, B. (1996). Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis.   Pancreas. 13(1), 96-99.

Pollock, M. L. & Wilmore, J. H. (1990).   Exercise in Health and Disease: Evaluation and Prescription for Prevention and Rehabilitation, Second Edition. Philadelphia: WB Saunders.

Post Coronary Artery Bypass Graft (CABG) Trial Investigators. (1997). The effect of aggressive lowering of LDL cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.   New England Journal of Medicine 336, 152-162.

Prabhakaran, B., Dowling, E. A., Branch, J. D., Swain, D. P. & Leutholtz, B. C. (1999). Effect of 14 weeks of resistance training on lipid profile and body fat percentage in premenopausal women.   British Journal of Sports Medicine. 33(3), 190-195.

Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.   Journal of the American College of Cardiology. 16, 340-348.

Rosenberg, L., Kaufman, D. W., Helmrich, S. P., & Shapiro, S. (1985). The risk of myocardial infarction after quitting smoking in men under 55 years of age.   New England Journal of Medicine. 313, 1511-1514.

Rosenberg, L., Miller, D. R., Kaufman, D. W., Helmrich, S. P., Van de Carr, S., Stolley, P. D. & Shapiro, S. (1983). Myocardial infarction in women under 50 years of age.   Journal of the American Medical Association;250(20), 2801-2806.

Rosenberg, L., Palmer, J. R. & Shapiro, S. (1990). Decline in the risk of myocardial infarction among women who stop smoking.   New England Journal of Medicine. 322, 213-217.

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, I., Schaefer, E. J., Schectman, G., Wilt, T. J. & Wittes, J. (1999). Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of HDL-C. Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial (VA-HIT) Study Group.   New England Journal of Medicine. 341(6), 410-418.

Russell, M. A. H., Wilson, C., Taylor, C. & Baker, C. D. (1979). Effect of general practitioners' advice against smoking.   British Medical Journal. 2, 231-235.

Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, F. W., Arnold, J. M., Davis, B. R., & Braunwald, E. (1996). Cholesterol and Recurrent Events Trial Investigators (CARE). The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.   New England Journal of Medicine. 335(14), 1001-1009.

Scandinavian Simvastatin Survival Study Group. (1994). Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).   Lancet. 344, 1383-1389.

Serruys, P, Foley, D., Jackson, G., Bonnier, H., Macaya, C., Vrolix, M., Branzi, A., Shepherd, J., Suryapranata, H., de Feyter, P., Melkert, R., van Es, G. & Pfister, P. (1999). A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.   European Heart Journal. 20(1), 58-69.

Shaffer, J. & Wexler, L. (1996). Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care.   Archives of Internal Medicine. 156(13), 1476-1479.

Sheills, J. F., Rubin, R., & Stapleton, D. C. (1999). The estimated costs and savings of medical nutrition therapy: the Medicare population.   Journal of the American Dietetic Association.99,428-432.

Shenberger, D. M., Helgren, R. J., Peters, J. R., Quiter, E., Johnston, E. A., & Hunninghake, D. B. (1992). Intense dietary counseling lowers LDL cholesterol in the recruitment phase of a clinical trial of men who had coronary artery bypass grafts.   Journal of the American Dietetic Association. 92(4), 441-445.

SHEP Cooperative Research Group. (1991). Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension.   Journal of the American Medical Association. 265, 3255-3264.

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., MacFarlane, P. W., McKillop, J. H. & Packard, C. J. (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group (WOSCPS).   New England Journal of Medicine. 333(20), 1301-1307.

Sikand, G., Kashyap, M. L., & Yang, I. (1989). Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia.   Journal of the American Dietetic Association. 98(8), 889-898.

Sikand G, et al. (1996). Beneficial outcome and cost savings with medical nutrition therapy by registered dietitians in hypercholesterolemia.   Journal of the American Dietetic Association. 9 Supplement:A-13.

Sikand, G., et al. (1997). Beneficial lipid outcome of medical nutrition therapy for men with combined hyperlipidemia in an ambulatory setting.   Journal of the American Dietetic Association. 9 Supplement:A-11.

Sikand, G., Kashyap, M. L., Yang, I. (1998). MNT lowers serum cholesterol and saves medication costs in men with hypercholesterolemia.   Journal of the American Dietetic Association. 98(8):889-898.

Snowden, C. B., McNamara, P. M., Garrison, R. J., Feinleib, M., Kannel, W. B., & Epstein, F. H. (1982). Predicting coronary heart disease in siblings-a multivariate assessment.   American Journal of Epidemiology.115(2), 217-222.

Society for Medical Decision Making Committee on Standardization of Clinical Algorithms. (1992). "Proposal for clinical algorithm standards," In   Medical Decision Making, 12(2), 149-154.

Spate-Douglas, T. & Keyser, P. E. (1999). Exercise intensity: its effect on the high-density lipoprotein profile.   Archives of Physical Medicine Rehabilitation. 80(6), 691-695.

Splett, P. L. (1996). Cost Outcomes of Intervention: Economic and Cost Analysis of Nutrition Intervention, Part 3. Evansville, IN: Mead Johnson & Company.

Stamler, J. (1988). Risk factor modification trials: implications for the elderly.   European Heart Journal. 9(suppl D), 9-53.

Stamler, J., Vaccaro, O., Neaton, J. D. & Wentworth, D. (1993). Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial.   Diabetes Care. 16(2), 434-444.

Stein, R. A., Michielli, D. W., Glantz, J. D., Sardy, H., Cohen, A., Goldberg, N. & Brown, C. D. (1990). Effects of different exercise training intensities on lipoprotein cholesterol fractions in healthy middle-aged men.   American Heart Journal. 119(2 Pt 1), 277-283.

Stinnett, A. A., Mittleman, M. A., Weinstein, M. C., Kuntz, K. M., Cohen, D. J., Williams, L. W., Goldman, P. A., Staiger, D. O., Hunink, M. G. M., Tsevat, J., Tosteson, A. N. A., & Goldman, L. The Cost Effectiveness of Dietary and Pharmacologic Therapy for Cholesterol Reduction in Adults. In: Gold, M. R., Siegal, J. E., Russell, L. B., & Weinstein, M. C. (eds). (1996).   Cost Effectiveness in Health and Medicine. First Edition. New York: Oxford University Press.

Stone, N. J. (1997). Management of Lipids in Clinical Practice. Professional Communications, Inc. ISBN 1-884735-22-3.

Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults.   Journal of the American Medical Association. 269, 3015-3022.

The Cost of Covering Medical Nutrition Therapy Services under TRICARE: Benefit Costs, Cost Avoidance and Savings, The Lewin Group, Inc., 1998.

The U.S. Preventive Services Task Force Guide to Clinical Preventive Services. Second Edition (1996). 15-38.

Thompson, S. G., Pocock, S. J. (1990). The variability of serum cholesterol measurements: implications for screening and monitoring.   Journal of Clinical Epidemiology. 43, 783-789.

Tillotson, J. L., Grandits, G. A., Bartsch, G. E. & Stamler, J. (1997). Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the multiple risk factor intervention trial (MRFIT).   American Journal of Clinical Nutrition. 65(supplement):314S-26.

Tosteson, A. N. A., Weinstein, M. C., Hunink, M. G. M., Mittleman, M. A., Williams, L. W., Goldman, P. A., Goldman, L. (1997). Cost-effectiveness of population wide educational approaches to reduce serum cholesterol levels.   Circulation. 95:24-30.

Ulbright, T. L. V. & Soughgate, D. A. T. (1991). Coronary heart disease: seven dietary factors.   Lancet. 338, 985-992.

United Kingdom Prospective Diabetes Study Group (UKPDS). (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.   Lancet 353, 837-853.

U.S. Department of Agriculture, U.S. Department of Health and Human Services: Nutrition and Your Health: Dietary Guidelines for Americans. Fourth Edition. Hyattsville, MD, USDA's Human Nutrition Information Service, 1992.

U.S. Department of Health and Human Services. (1989). Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. DHHS Publication No. (PHS) (CDC) 8489-8411.

U.S. Department of Health and Human Services. Public Health Service. (1998). Clinician's Handbook of Preventive Services: Put Prevention into Practice. Second Edition.

U.S. Preventive Services Task Force. (1996). Guide to Clinical Services Preventive Services. Second Edition. Alexandria, Virginia: International Medical Publishing.

VA 1996 External Peer Review Program, Contract No. V101(93) P-1369.

VA-HIT. See Rubins.

VHA Directive 96-053, (August 29, 1996). Roles and Definitions for Clinical Practice Guidelines and Clinical Pathways.

Wei, M., Macera, C.A., Hornung, C.A., Blair, S.N. (1997). Changes in lipids associated with change in regular exercise in free-living men.   Journal of Clinical Epidemiology. 50(10), 1137-1142.

West of Scotland Coronary Prevention Study. (1999). The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men.   Journal of the American College of Cardiology. 33(4), 909-915.

Wilson, P.W., Abbott, R.D., Castelli, W.P. (1988). High density lipoprotein cholesterol and mortality: the Framingham Heart Study.   Arteriosclerosis. 8, 737-741.

Wilson, P.W., D'Agostino, R.B., Levy, D., Belanger, A.M., Silbershatz, H., Kannel, W.B. (1998). Prediction of coronary heart disease using risk factor categories.   Circulation. 97(18):1837-1847.

Wingard, D.L., Barrett-Connor, E., Criqui, M.H., Suarez, L. (1983). Clustering of heart disease risk factors in diabetic compared to non-diabetic adults.   American Journal of Epidemiology. 117(1),19-26.

Wood, D.A., De Backer, G., Faergeman, O., Graham, I., Mancia, G., Pyorala, K. (1998). Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of the European Society of Cardiology and other societies on coronary prevention.   Atherosclerosis.140(2), 199-270.

Wood, P.D., Haskell, W.L., Blair, S.N., William, P.T., Krauss, R.M., Lindgren, F.T., Albers, J.J., Ho, P.H., Farquhar, J.W. (1983). Increased exercise level and plasma lipoprotein concentrations: A one-year randomized, controlled study of sedentary middle-aged men.   Metabolism. 32, 31-39

Woolf, S. H. (May 1992) Practice guidelines, a new reality in medicine II. Methods of developing guidelines.   Archives of Internal Medicine, 152. 947-948.

Woolf, S. H. (Dec 1993). Practice guidelines, a new reality in medicine III. Impact on patient care.   Archives of Internal Medicine, 153, 2647.

Zimmerman, F.H., Cameron, A., Fisher, L.D., Grace, N. (1995). Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry).   Journal American College Cardiology. 26, 654-661.